These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24268047)

  • 1. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
    Huang P; Xu X; Wang L; Zhu B; Wang X; Xia J
    J Cell Mol Med; 2014 Feb; 18(2):218-30. PubMed ID: 24268047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
    Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cells.
    Wang Y; Wang W; Wang L; Wang X; Xia J
    J Cell Mol Med; 2012 Mar; 16(3):496-506. PubMed ID: 21545687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
    Cheng X; Chen M; Liu Z
    Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Zhangyuan G; Wang F; Zhang H; Jiang R; Tao X; Yu D; Jin K; Yu W; Liu Y; Yin Y; Shen J; Xu Q; Zhang W; Sun B
    Oncogene; 2020 Feb; 39(6):1213-1230. PubMed ID: 31605014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
    Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells.
    Haim K; Weitzenfeld P; Meshel T; Ben-Baruch A
    Neoplasia; 2011 Mar; 13(3):230-43. PubMed ID: 21390186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.
    Tveteraas IH; Müller KM; Aasrum M; Ødegård J; Dajani O; Guren T; Sandnes D; Christoffersen T
    J Exp Clin Cancer Res; 2012 Sep; 31(1):72. PubMed ID: 22967907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Koch A; Evers BM
    Anticancer Res; 2010 Dec; 30(12):4951-8. PubMed ID: 21187475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma.
    Hennig M; Yip-Schneider MT; Klein P; Wentz S; Matos JM; Doyle C; Choi J; Wu H; O'Mara A; Menze A; Noble S; McKillop IH; Schmidt CM
    J Surg Res; 2009 Jun; 154(2):187-95. PubMed ID: 19321179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox9/CXCL5 axis facilitates tumour cell growth and invasion in hepatocellular carcinoma.
    Ren Z; Chen Y; Shi L; Shao F; Sun Y; Ge J; Zhang J; Zang Y
    FEBS J; 2022 Jun; 289(12):3535-3549. PubMed ID: 35038357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
    Lim WC; Kim H; Ko H
    J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
    Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
    PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MYLK-AS1 promotes growth and invasion of hepatocellular carcinoma through the EGFR/HER2-ERK1/2 signaling pathway.
    Liu J; Zhao SY; Jiang Q; Qu Y; Huang X; Du J; Sun W; Ye Q
    Int J Biol Sci; 2020; 16(11):1989-2000. PubMed ID: 32398965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway.
    Zhang Y; Wang L; Zhang M; Jin M; Bai C; Wang X
    J Cell Physiol; 2012 Jan; 227(1):35-43. PubMed ID: 21412767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
    Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
    Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma.
    Wang LL; Luo J; He ZH; Liu YQ; Li HG; Xie D; Cai MY
    Cell Death Dis; 2021 Nov; 12(11):1052. PubMed ID: 34741044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.